Medtronic gets FDA nod for next-gen, MRI-friendly pacer

Medtronic gained FDA approval for the Advisa DR MRI SureScan pacer.--Courtesy of Medtronic

Medtronic ($MDT) gained FDA approval for what will become its second MRI-friendly pacer in the United States, and only the second device of its kind to gain a regulatory nod here. Plans call for immediately rolling out the Advisa DR MRI SureScan pacer for marketing.

How time flies. Barely two years ago, Medtronic won the FDA's sign-off for the Revo MRI SureScan pacing system, the first MRI-friendly pacer kind to gain approval in the U.S. (Traditional pacemakers aren't MRI friendly). But a lot has changed in the market since then. Since 2011, Medtronic obtained a CE mark for Revo, and aggressively pursued development and testing of the next-generation Advisa MRI both abroad and in the U.S. And competition is rising; Rival St. Jude Medical ($STJ), for example, is pursuing a broad clinical trial for the Accent MRI, its own full-body MRI friendly pacemaker designed to allow widespread MRI scans rather than just at certain measurements and spots in the body. And Biotronik gained FDA approval in January to begin a U.S. clinical trial for its own MRI-safe pacemaker.

Medtronic's win of a second FDA approval for an MRI-friendly pacemaker is also noteworthy because it has been harder for these devices to pass regulatory muster here. The company, by contrast, has been selling SureScan-related pacers in Europe since 2008.

For Advisa MRI, the company won U.S. regulatory approval based on a pivotal trial involving 156 patients (fitted with special MRI-friendly leads). None of the patients were left with MRI-related problems, according to the company. Advisa MRI also has a number of updated bells and whistles, including technology designed to extend the device's lifespan, and diagnostics software that helps physicians detect and treat atrial fibrillation on the early side.

MRI-friendly implants and medical devices are becoming increasingly important to global healthcare. As many as 75% of patients globally who have implanted cardiac devices will need an MRI scan sometime during the life of their devices, Medtronic notes.

- read the release

Related Articles:
FDA greenlights trial of Biotronik's MRI-safe pacemaker
Medtronic launches MRI-safe pacemaker in Japan
ICDs and pacemakers may be safe for MRI use after all
St. Jude starts clinical trial of full-body MRI-friendly pacemaker

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.